to $11.8 trillion, with North America making up forecasting firm BMI,3 covering 186 countries roughly 50% of the total at $5.5 trillion, followed globally, foresee global spending of as much as $18.4 trillion by 2034 with a yearly CAGR reaching by Europe with $2.6 trillion, China at $600 billion, 4.9% between 2015 and 2034. This reports Japan at $500 billion, India at $100 billion, and other developing markets at $2.5 trillion. region-specific assumptions on demographic shifts, disease prevalence, and anticipated care needs affordability in the future, this analysis extends its projections through 2040, based on proprietary regional expenditure data available. The most from $11.8 trillion in 2025 to $23.1 trillion by 2040 at a 4.6% CAGR (with up- and downside scenarios ranging from $20.8 trillion to $26.1 trillion). Regardless of which projection one chooses, and Development (OECD), generally extend only to 2030, reflecting both data limitations and rising uncertainty over longer horizons. In a widely economies. For instance, most economic analyses in The Lancet 2017,2 global healthcare spending project that the US GDP will grow between 1.7% and 2.3% per annum over the next 15 years. an uncertainty array of up to $29.7 trillion and That means in the best case, GDP growth will